Rein Therapeutics, Inc.
RNTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001420565
No open-market purchases or sales by Rein Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $42.3M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Rein Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −13 vs. Q3 2022
- Shares held
- 1.36M
- −57.4K (−4.1%) vs. Q3 2022Converted for a 1-for-20 split
- Total value
- $3.21M
- −$2.64M (−45.1%) vs. Q3 2022
- New holders
- 2
- 5 more added
- Sold out
- 15
- 4 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RNTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 59 | $42.3M |
| Q1 2026 | 46 | $14.8M |
| Q4 2025 | 48 | $12.5M |
| Q3 2025 | 40 | $9.76M |
| Q2 2025 | 36 | $9.30M |
| Q1 2025 | 39 | $10.6M |
| Q4 2024 | 31 | $13.1M |
| Q3 2024 | 32 | $16.3M |
| Q2 2024 | 29 | $13.5M |
| Q1 2024 | 23 | $11.0M |
| Q4 2023 | 20 | $3.24M |
| Q3 2023 | 16 | $1.59M |
| Q2 2023 | 17 | $1.83M |
| Q1 2023 | 19 | $1.30M |
| Q4 2022 | 19 | $3.21M |
| Q3 2022 | 33 | $5.86M |
| Q2 2022 | 37 | $8.34M |
| Q1 2022 | 42 | $16.5M |
| Q4 2021 | 43 | $18.9M |
| Q3 2021 | 43 | $33.6M |
| Q2 2021 | 47 | $41.5M |
| Q1 2021 | 52 | $48.0M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Rein Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Satter Management Co., L.P. | 830,466 | $1.97M | 2.26% | 00.0% | UnchangedConverted for a 1-for-20 split |
| BVF Inc | 236,835 | $561.3K | 0.02% | −26,443−10.0% | ReducedConverted for a 1-for-20 split |
| Vanguard Group Inc | 130,315 | $308.8K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Blair William & Co | 67,867 | $160.8K | 0.00% | +6,527+10.6% | AddedConverted for a 1-for-20 split |
| Geode Capital Management, LLC | 44,488 | $105.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| KCK Ltd. | 22,341 | $52.9K | 0.08% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Renaissance Technologies LLC | 10,564 | $25.0K | 0.00% | +1,029+10.8% | AddedConverted for a 1-for-20 split |
| Advisor Group Holdings, Inc. | 3,656 | $9.00K | 0.00% | +333+10.0% | AddedConverted for a 1-for-20 split |
| UBS Group AG | 3,312 | $7.85K | 0.00% | +3,212+3,212.0% | AddedConverted for a 1-for-20 split |
| Tower Research Capital LLC (TRC) | 2,404 | $5.00K | 0.00% | +2,404 | New |
| JFS Wealth Advisors, LLC | 1,590 | $3.77K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| US Bancorp | 1,250 | $2.96K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Morgan Stanley | 1,250 | $2.96K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| BlackRock Inc. | 189 | $448 | 0.00% | −1−0.5% | ReducedConverted for a 1-for-20 split |
| Bank of America Corp | 183 | $433 | 0.00% | −2−1.1% | ReducedConverted for a 1-for-20 split |
| Wells Fargo & Company | 23 | $55 | 0.00% | +1+4.5% | AddedConverted for a 1-for-20 split |
| Acadian Asset Management LLC | 17 | $0 | 0.00% | −0−1.2% | ReducedConverted for a 1-for-20 split |
| Rockefeller Capital Management L.P. | 50 | $0 | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Royal Bank of Canada | 2 | $0 | 0.00% | +2 | New |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −9,201−100.0% | Sold outConverted for a 1-for-20 split |
| PVG Asset Management Corp | 0 | $0 | 0.00% | −5,880−100.0% | Sold outConverted for a 1-for-20 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −5,690−100.0% | Sold outConverted for a 1-for-20 split |
| State Street Corp | 0 | $0 | 0.00% | −5,104−100.0% | Sold outConverted for a 1-for-20 split |
| Game Plan Financial Advisors, LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold outConverted for a 1-for-20 split |
| Colony Group LLC | 0 | $0 | 0.00% | −4,516−100.0% | Sold outConverted for a 1-for-20 split |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −2,521−100.0% | Sold outConverted for a 1-for-20 split |
| Kestra Advisory Services, LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold outConverted for a 1-for-20 split |
| Cetera Investment Advisers | 0 | $0 | 0.00% | −1,312−100.0% | Sold outConverted for a 1-for-20 split |
| Mercer Global Advisors Inc | 0 | $0 | 0.00% | −1,005−100.0% | Sold outConverted for a 1-for-20 split |
| LPL Financial LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold outConverted for a 1-for-20 split |
| Lake Street Advisors Group, LLC | 0 | $0 | 0.00% | −825−100.0% | Sold outConverted for a 1-for-20 split |
| Millennium Management LLC | 0 | $0 | 0.00% | −600−100.0% | Sold outConverted for a 1-for-20 split |
| Ridgecrest Wealth Partners, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold outConverted for a 1-for-20 split |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold outConverted for a 1-for-20 split |
| Kore Private Wealth LLC | – | – | – | – | Not filed |